Storm Therapeutics
Clinical-stage biotech developing small-molecule RNA modifying enzyme inhibitors for cancer and other diseases
Highlights
- New on EvolcAdded 2026-10-28
About Storm Therapeutics
STORM Therapeutics is a clinical-stage biotechnology company that develops small-molecule drugs targeting RNA modifying enzymes. Its lead product, STC-15, is a METTL3 inhibitor that is being evaluated in a Phase 2 study in patients with select sarcomas. The company describes STC-15 as the first RNA modifying enzyme inhibitor to enter human clinical development.
The company's R&D draws on chemical biology, RNA sequencing, RNA mass spectrometry and functional genomics to identify and validate drug targets. Its stated focus areas are cancer, inflammation, viral infections and CNS diseases.
STORM is headquartered in Waterbeach, UK, and presents Cambridge, UK as its location. It was founded in 2015. In April 2026 it announced a $56 million Series C financing and the first patient dosed in its Phase 2 sarcoma trial of STC-15. Its leadership team includes a CEO and President, a Chief Business Officer, a Chief Development Officer and a consulting Chief Medical Officer.
Product: STC-15, a METTL3 inhibitor in Phase 2 clinical development for select sarcomas; RNA modifying enzyme drug discovery platform
Jobs at Storm Therapeutics
Leadership
- Jerry McMahon · Chief Executive Officer & PresidentSource: company website
More biotech & pharma companies
Sygnature Discovery
Contract drug discovery services for biotech and pharma firms, spanning chemistry, biology, structural work and preclinical studiesNew on EvolcSynthace
Experiment design, lab automation and AI-ready data software for drug discovery and life science R&D teamsNew on EvolcT-Cypher Bio
Develops immune engager drugs for cancer and autoimmune diseases, built on proprietary wet-lab and computational platformsNew on EvolcTheolytics
Develops oncolytic adenovirus immunotherapies for patients with solid tumours and cancers of high unmet needNew on EvolcTheramex
Specialty pharmaceuticals for women’s health, including contraception, fertility, menopause and osteoporosis treatmentsRemote-friendlyTithonia Group
Specialty pharma group that runs a medicine licensing and distribution platform and product brands for prescribers and patients in EuropeNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Apache
- Google Universal Analytics
- Google reCAPTCHA